Is protracted low-dose temozolomide feasible in glioma patients? [electronic resource]
Producer: 20060505Description: 427-9 p. digitalISSN:- 1526-632X
- Adult
- Aged
- Antineoplastic Agents, Alkylating -- administration & dosage
- Central Nervous System Neoplasms -- drug therapy
- Dacarbazine -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Feasibility Studies
- Female
- Glioma -- drug therapy
- Humans
- Infections -- etiology
- Lymphopenia -- chemically induced
- Male
- Middle Aged
- Temozolomide
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.